These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

5551 related items for PubMed ID: 3681346

  • 21. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice.
    Kawai K, Enomoto T, Fornasier V, Resetkova E, Volpé R.
    Proc Assoc Am Physicians; 1997 Mar; 109(2):126-35. PubMed ID: 9069581
    [Abstract] [Full Text] [Related]

  • 22. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
    Furrer M, Altermatt HJ, Ris HB, Althaus U, Rüegg C, Liénard D, Lejeune FJ.
    Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
    [Abstract] [Full Text] [Related]

  • 23. Acute myeloid leukemic cell lines loaded with synthetic dsRNA trigger IFN-gamma secretion by human NK cells.
    Lion E, Smits EL, Berneman ZN, Van Tendeloo VF.
    Leuk Res; 2009 Apr; 33(4):539-46. PubMed ID: 18845337
    [Abstract] [Full Text] [Related]

  • 24. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta.
    Borden EC, Sidky YA, Hatcher JF, Bryan GT.
    Cancer Res; 1988 May 01; 48(9):2329-34. PubMed ID: 3356000
    [Abstract] [Full Text] [Related]

  • 25. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW, Karashima T, Perrotte P, Inoue K, Kim SJ, Izawa J, Kedar D, McConkey DJ, Millikan R, Sweeney P, Yoshikawa C, Shuin T, Dinney CP.
    Clin Cancer Res; 2001 Sep 01; 7(9):2840-53. PubMed ID: 11555602
    [Abstract] [Full Text] [Related]

  • 26. Synergistic therapeutic effect of combination therapy with OK-432 and interferon-alpha or -gamma on Meth-A ascites tumor in BALB/c mice.
    Mizushima Y, Morikage T, Hirata H, Sato M, Sakamoto K, Yano S.
    J Biol Response Mod; 1988 Aug 01; 7(4):371-83. PubMed ID: 3139841
    [Abstract] [Full Text] [Related]

  • 27. Antiproliferative and cytotoxic effects of single and combined treatment with tumor necrosis factor alpha and/or alpha interferon on a human renal cell carcinoma xenotransplanted into nu/nu mice: cell kinetic studies.
    Baisch H, Otto U, Klöppel G.
    Cancer Res; 1990 Oct 01; 50(19):6389-95. PubMed ID: 2400997
    [Abstract] [Full Text] [Related]

  • 28. Therapeutic effect of intravenous delivery of lipoplexes containing the interferon-beta gene and poly I: poly C in a murine lung metastasis model.
    Sakurai F, Terada T, Maruyama M, Watanabe Y, Yamashita F, Takakura Y, Hashida M.
    Cancer Gene Ther; 2003 Sep 01; 10(9):661-8. PubMed ID: 12944985
    [Abstract] [Full Text] [Related]

  • 29. In vitro anti-tumour activity of alpha-galactosylceramide-stimulated human invariant Valpha24+NKT cells against melanoma.
    Kikuchi A, Nieda M, Schmidt C, Koezuka Y, Ishihara S, Ishikawa Y, Tadokoro K, Durrant S, Boyd A, Juji T, Nicol A.
    Br J Cancer; 2001 Sep 01; 85(5):741-6. PubMed ID: 11531261
    [Abstract] [Full Text] [Related]

  • 30. Effect of murine alpha-, beta-, and gamma-interferons in combination with alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, on the tumor growth and metastasis of B16 melanoma and Lewis lung carcinoma in mice.
    Sunkara PS, Bowlin TL, Rosenberger AL, Fleischmann WR.
    J Biol Response Mod; 1989 Apr 01; 8(2):170-9. PubMed ID: 2499664
    [Abstract] [Full Text] [Related]

  • 31. In vitro-generated viral double-stranded RNA in contrast to polyinosinic:polycytidylic acid induces interferon-alpha in human plasmacytoid dendritic cells.
    Löseke S, Grage-Griebenow E, Heine H, Wagner A, Akira S, Bauer S, Bufe A.
    Scand J Immunol; 2006 Apr 01; 63(4):264-74. PubMed ID: 16623926
    [Abstract] [Full Text] [Related]

  • 32. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1999 Feb 01; 469():1-361. PubMed ID: 12579204
    [Abstract] [Full Text] [Related]

  • 33. [Antitumor effects of recombinant human leukocyte interferon (rIFN-alpha A) on human malignomas transplanted into nude mice].
    Hashizume S.
    Gan To Kagaku Ryoho; 1985 Feb 01; 12(2):284-8. PubMed ID: 3970552
    [Abstract] [Full Text] [Related]

  • 34. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo.
    Lindner DJ, Borden EC, Kalvakolanu DV.
    Clin Cancer Res; 1997 Jun 01; 3(6):931-7. PubMed ID: 9815768
    [Abstract] [Full Text] [Related]

  • 35. IFN-producing killer dendritic cells contribute to the inhibitory effect of poly I:C on the progression of murine melanoma.
    Jiang Q, Wei H, Tian Z.
    J Immunother; 2008 Jun 01; 31(6):555-62. PubMed ID: 18528299
    [Abstract] [Full Text] [Related]

  • 36. [Application of interleukin 1 in the treatment of malignant gliomas with special reference to the experimental combination therapy with ACNU].
    Tanaka S.
    Gan To Kagaku Ryoho; 1990 Jun 01; 17(6):1157-64. PubMed ID: 2350191
    [Abstract] [Full Text] [Related]

  • 37. Antiproliferative and antitumor effects of alpha-interferon in renal cell carcinomas: correlation with the expression of a kidney-associated differentiation glycoprotein.
    Nanus DM, Pfeffer LM, Bander NH, Bahri S, Albino AP.
    Cancer Res; 1990 Jul 15; 50(14):4190-4. PubMed ID: 2364374
    [Abstract] [Full Text] [Related]

  • 38. Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus.
    Bukowski JF, Biron CA, Welsh RM.
    J Immunol; 1983 Aug 15; 131(2):991-6. PubMed ID: 6190947
    [Abstract] [Full Text] [Related]

  • 39. Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery.
    Da Costa ML, Redmond HP, Bouchier-Hayes DJ.
    J Surg Res; 2001 Dec 15; 101(2):111-9. PubMed ID: 11735264
    [Abstract] [Full Text] [Related]

  • 40. Effects of monoclonal antibody, recombinant interferon-gamma, and tumor necrosis factor-alpha in the treatment of human melanoma xenografts.
    Gridley DS, Slater JM, Stickney DR.
    J Biol Response Mod; 1989 Dec 15; 8(6):593-602. PubMed ID: 2513378
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 278.